5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | NEUTRAL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 4.89▲ | 4.90▼ | 4.88▲ | 5.30▼ | 5.04▼ |
MA10 | 4.88▲ | 4.90▼ | 4.97▼ | 5.07▼ | 4.48▲ |
MA20 | 4.90▼ | 4.98▼ | 5.30▼ | 5.01▼ | 3.31▲ |
MA50 | 4.90▼ | 5.29▼ | 5.06▼ | 4.16▲ | 3.82▲ |
MA100 | 4.99▼ | 5.04▼ | 4.95▼ | 3.21▲ | 9.54▼ |
MA200 | 5.33▼ | 4.93▼ | 4.81▲ | 3.50▲ | 29.94▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.002▲ | -0.002▼ | -0.072▼ | -0.032▼ | 0.399▲ |
RSI | 49.833▼ | 41.453▼ | 42.759▼ | 51.546▲ | 55.206▲ |
STOCH | 53.084 | 33.718 | 13.612▼ | 56.718 | 71.327 |
WILL %R | -54.167 | -76.136▼ | -90.455▼ | -70.161 | -29.276 |
CCI | -7.595 | -59.876 | -81.436 | -0.391 | 83.124 |
Tuesday, July 08, 2025 06:39 AM
Baystreet.ca News Commentary – With cancer cases rising and treatment costs hitting new highs, the private sector is under growing pressure to lead the next wave of innovation.
|
Monday, July 07, 2025 09:20 AM
LEXINGTON, MA, USA I July 07, 2025 I Agenus Inc. (Nasdaq: AGEN) a leader in immuno-oncology innovation, today announced that its botensilimab and balstilimab ...
|
Thursday, July 03, 2025 01:42 PM
Agenus Announces Virtual Annual Shareholders Meeting. LEXINGTON, Mass., June 10, 2025--Agenus Inc. ("Agenus") (NASDAQ: AGEN), a leader in immuno-oncology innovation, today announced that its ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
08/07/25 | 5.18 | 5.225 | 4.79 | 4.895 | 977,140 |
07/07/25 | 5.96 | 5.98 | 4.85 | 5.18 | 2,131,700 |
03/07/25 | 5.51 | 6.20 | 5.4841 | 6.07 | 1,273,135 |
02/07/25 | 4.84 | 5.60 | 4.81 | 5.51 | 1,119,318 |
01/07/25 | 4.52 | 5.05 | 4.34 | 4.84 | 1,090,524 |
30/06/25 | 4.80 | 4.93 | 4.52 | 4.57 | 677,318 |
27/06/25 | 4.91 | 5.22 | 4.75 | 4.76 | 3,866,166 |
26/06/25 | 5.00 | 5.02 | 4.81 | 4.91 | 858,728 |
25/06/25 | 5.06 | 5.06 | 4.71 | 4.93 | 677,151 |
24/06/25 | 4.83 | 5.18 | 4.83 | 5.00 | 823,733 |
|
|
||||
|
|
||||
|
|